These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 21102240)

  • 1. Vaccines and immunotherapy for non-small cell lung cancer.
    Morgensztern D; Goodgame B; Govindan R
    J Thorac Oncol; 2010 Dec; 5(12 Suppl 6):S463-5. PubMed ID: 21102240
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic cancer vaccines in the treatment of non-small-cell lung cancer.
    Limacher JM; Spring-Giusti C; Bellon N; Ancian P; Rooke R; Bonnefoy JY
    Expert Rev Vaccines; 2013 Mar; 12(3):263-70. PubMed ID: 23496666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is vaccine therapy a renewed strategic approach for non-small-cell lung cancer therapy?
    Rossi A
    Expert Rev Vaccines; 2013 Jan; 12(1):5-7. PubMed ID: 23256734
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunotherapy in non-small-cell lung carcinoma: from inflammation to vaccination.
    Van den Heuvel MM; Burgers SA; van Zandwijk N
    Clin Lung Cancer; 2009 Mar; 10(2):99-105. PubMed ID: 19362952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active immunotherapy for non-small-cell lung cancer: moving toward a reality.
    Perez CA; Santos ES; Raez LE
    Expert Rev Anticancer Ther; 2011 Oct; 11(10):1599-605. PubMed ID: 21999133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung cancer vaccine demonstrates enhanced antitumor immunity.
    Oncology (Williston Park); 2001 Jan; 15(1):36, 83. PubMed ID: 11271980
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunotherapy: is a minor god yet in the pantheon of treatments for lung cancer?
    Rolfo C; Sortino G; Smits E; Passiglia F; Bronte G; Castiglia M; Russo A; Santos ES; Janssens A; Pauwels P; Raez L
    Expert Rev Anticancer Ther; 2014 Oct; 14(10):1173-87. PubMed ID: 25148289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Progress in Immunotherapy for Squamous Non-small Cell Lung Cancer].
    Wang S; Li J
    Zhongguo Fei Ai Za Zhi; 2016 Oct; 19(10):682-686. PubMed ID: 27760599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Belagenpumatucel-L for the treatment of non-small cell lung cancer.
    Rijavec E; Biello F; Genova C; Barletta G; Maggioni C; Dal Bello MG; Coco S; Truini A; Vanni I; Alama A; Beltramini S; Grassi MA; Boccardo F; Grossi F
    Expert Opin Biol Ther; 2015; 15(9):1371-9. PubMed ID: 26211534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer vaccines: a new therapeutic alternative for lung cancer therapy?
    Raez LE; Santos ES
    Immunotherapy; 2009 Sep; 1(5):727-8. PubMed ID: 20636014
    [No Abstract]   [Full Text] [Related]  

  • 11. The state of the art in non-small cell lung cancer immunotherapy.
    Seetharamu N
    Semin Thorac Cardiovasc Surg; 2014; 26(1):26-35. PubMed ID: 24952755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccines in non-small cell lung cancer: rationale, combination strategies and update on clinical trials.
    De Pas T; Giovannini M; Rescigno M; Catania C; Toffalorio F; Spitaleri G; Delmonte A; Barberis M; Spaggiari L; Solli P; Veronesi G; De Braud F
    Crit Rev Oncol Hematol; 2012 Sep; 83(3):432-43. PubMed ID: 22366114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harnessing the immune system for the treatment of non-small-cell lung cancer.
    Brahmer JR
    J Clin Oncol; 2013 Mar; 31(8):1021-8. PubMed ID: 23401435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trials targeting lung cancer with active immunotherapy: the scope of vaccines.
    Raez LE; Santos ES; Mudad R; Podack ER
    Expert Rev Anticancer Ther; 2005 Aug; 5(4):635-44. PubMed ID: 16111464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic vaccines explored in patients with non-small cell lung cancer.
    Ma K; Tang YH
    Anticancer Agents Med Chem; 2014 Feb; 14(2):256-64. PubMed ID: 24237217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selecting patients for immune checkpoint inhibition in lung cancer.
    Garon EB
    Clin Adv Hematol Oncol; 2015 Aug; 13(8):490-2. PubMed ID: 26351808
    [No Abstract]   [Full Text] [Related]  

  • 17. Emepepimut-S for non-small cell lung cancer.
    Corrales-Rodriguez L; Blais N; Soulières D
    Expert Opin Biol Ther; 2011 Aug; 11(8):1091-7. PubMed ID: 21689064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pilot study of 1650-G: a simplified cellular vaccine for lung cancer.
    Hirschowitz EA; Mullins A; Prajapati D; Baeker T; Kloecker G; Foody T; Damron K; Love C; Yannelli JR
    J Thorac Oncol; 2011 Jan; 6(1):169-73. PubMed ID: 21150468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cell vaccines against non-small cell lung cancer -  an emerging therapeutic alternative.
    Mendoza L
    Klin Onkol; 2014; 27(4):294-8. PubMed ID: 25115721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Updates on immunotherapy in non-small cell lung cancer.
    Shimanovsky A; Dasanu CA
    Expert Opin Biol Ther; 2014 Apr; 14(4):411-8. PubMed ID: 24512518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.